ETF Components for AGNG - Global X Aging Population ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
WELL A 0.00 4.21
BSX A 0.00 3.60
BMY B 0.00 3.37
SYK A 0.00 3.13
AMGN D 0.00 3.10
MDT D 0.00 2.96
LLY F 0.00 2.93
JNJ D 0.00 2.89
ABBV F 0.00 2.86
AZN F 0.00 2.65
REGN F 0.00 2.40
VTR B 0.00 2.18
EW C 0.00 2.04
ZBH C 0.00 1.90
BGNE D 0.00 1.58
PODD B 0.00 1.56
UTHR C 0.00 1.55
DXCM C 0.00 1.51
INCY C 0.00 1.49
DVA C 0.00 1.15
NBIX C 0.00 1.04
EXEL B 0.00 0.90
OHI C 0.00 0.83
EXAS D 0.00 0.79
TFX F 0.00 0.76
ENSG D 0.00 0.70
GKOS A 0.00 0.58
HALO F 0.00 0.58
AGIO C 0.00 0.51
BPMC C 0.00 0.50
MMSI A 0.00 0.50
MNKD B 0.00 0.46
DNLI D 0.00 0.42
NHC C 0.00 0.40
ITGR B 0.00 0.38
EMBC C 0.00 0.38
NHI D 0.00 0.37
SBRA B 0.00 0.37
NVCR C 0.00 0.33
LTC B 0.00 0.33
TBPH B 0.00 0.30
AMED F 0.00 0.28
LIVN D 0.00 0.27
ACAD C 0.00 0.27
ALEC F 0.00 0.22
BKD F 0.00 0.22
ATEC C 0.00 0.18
AGL F 0.00 0.09

Recent News for Global X Aging Population ETF & its Holdings

Date Stock Title
Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
Nov 20 PODD Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
Nov 20 VTR Ventas Earns Nareit 2024 Healthcare "Leader in the Light" Award
Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20 MDT Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth
Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 20 DVA When Should You Buy DaVita Inc. (NYSE:DVA)?
Nov 20 OHI CIO or OHI: Which Is the Better Value Stock Right Now?
Nov 20 LLY More companies covering weight loss drugs for their employees
Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 MDT Medtronic reports rise in Q2 FY 2025 net income to $1.27bn
Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Biotechnology Structured Finance Pharmaceutical Financial Market Health Care Services
Back to the Main AGNG Page...